Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.

NCT00034203 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT00034203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
August 31, 2003
Enrollment
Not reported
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis